Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients
Among those who study granulomatous diseases, sarcoidosis is of tremendous interest, not only because its cause is unknown, but also because it is still as much an enigma today as it was 150 years ago when Jonathan Hutchinson first described the cutaneous form of the disease as “livid papillary psor...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-08-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/11/8/1401 |
| _version_ | 1797524146050039808 |
|---|---|
| author | Jotam G. Pasipanodya |
| author_facet | Jotam G. Pasipanodya |
| author_sort | Jotam G. Pasipanodya |
| collection | DOAJ |
| description | Among those who study granulomatous diseases, sarcoidosis is of tremendous interest, not only because its cause is unknown, but also because it is still as much an enigma today as it was 150 years ago when Jonathan Hutchinson first described the cutaneous form of the disease as “livid papillary psoriasis”. This piece editorializes a comparative effectiveness study of methotrexate versus methylprednisolone in treatment naïve pulmonary sarcoidosis patients for CT-guided clinical responses and drug-related adverse events. |
| first_indexed | 2024-03-10T08:53:14Z |
| format | Article |
| id | doaj.art-06652458eac9458384601fb0ebf81f1a |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-10T08:53:14Z |
| publishDate | 2021-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-06652458eac9458384601fb0ebf81f1a2023-11-22T07:19:58ZengMDPI AGDiagnostics2075-44182021-08-01118140110.3390/diagnostics11081401Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis PatientsJotam G. Pasipanodya0Independent Researcher, 14830 Venture Drive, Dallas, TX 75234, USAAmong those who study granulomatous diseases, sarcoidosis is of tremendous interest, not only because its cause is unknown, but also because it is still as much an enigma today as it was 150 years ago when Jonathan Hutchinson first described the cutaneous form of the disease as “livid papillary psoriasis”. This piece editorializes a comparative effectiveness study of methotrexate versus methylprednisolone in treatment naïve pulmonary sarcoidosis patients for CT-guided clinical responses and drug-related adverse events.https://www.mdpi.com/2075-4418/11/8/1401sarcoidosismachine learningtreatment outcomes |
| spellingShingle | Jotam G. Pasipanodya Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients Diagnostics sarcoidosis machine learning treatment outcomes |
| title | Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients |
| title_full | Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients |
| title_fullStr | Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients |
| title_full_unstemmed | Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients |
| title_short | Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients |
| title_sort | comparative effectiveness of methotrexate versus methylprednisolone in treatment naive pulmonary sarcoidosis patients |
| topic | sarcoidosis machine learning treatment outcomes |
| url | https://www.mdpi.com/2075-4418/11/8/1401 |
| work_keys_str_mv | AT jotamgpasipanodya comparativeeffectivenessofmethotrexateversusmethylprednisoloneintreatmentnaivepulmonarysarcoidosispatients |